| __timestamp | Ligand Pharmaceuticals Incorporated | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 9136000 | 9216000000 |
| Thursday, January 1, 2015 | 5807000 | 8296000000 |
| Friday, January 1, 2016 | 5571000 | 10044000000 |
| Sunday, January 1, 2017 | 5366000 | 11560000000 |
| Monday, January 1, 2018 | 6337000 | 10558000000 |
| Tuesday, January 1, 2019 | 11347000 | 9351000000 |
| Wednesday, January 1, 2020 | 30419000 | 8933000000 |
| Friday, January 1, 2021 | 62176000 | 8284000000 |
| Saturday, January 1, 2022 | 52827000 | 7952000000 |
| Sunday, January 1, 2023 | 35049000 | 8200000000 |
| Monday, January 1, 2024 | 8480000000 |
Unveiling the hidden dimensions of data
In the ever-evolving pharmaceutical industry, understanding the cost of revenue is crucial for assessing a company's financial health. This analysis focuses on Teva Pharmaceutical Industries Limited and Ligand Pharmaceuticals Incorporated, two prominent players in the sector. From 2014 to 2023, Teva's cost of revenue consistently dwarfed Ligand's, averaging around 9.2 billion annually, compared to Ligand's 22 million. Notably, Teva's cost peaked in 2017 at approximately 11.6 billion, while Ligand saw its highest cost in 2021, reaching 62 million. Over the decade, Teva's cost of revenue decreased by about 14%, reflecting strategic cost management. In contrast, Ligand experienced a staggering 580% increase, indicating significant operational expansion. This data provides a fascinating glimpse into the contrasting financial strategies of these pharmaceutical titans, highlighting the diverse paths companies can take in pursuit of growth and sustainability.
Cost of Revenue Trends: Bristol-Myers Squibb Company vs Teva Pharmaceutical Industries Limited
Zoetis Inc. vs Ligand Pharmaceuticals Incorporated: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Teva Pharmaceutical Industries Limited vs Pharming Group N.V.
Cost of Revenue: Key Insights for Teva Pharmaceutical Industries Limited and Lantheus Holdings, Inc.
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Veracyte, Inc.
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Amphastar Pharmaceuticals, Inc.
Cost Insights: Breaking Down Teva Pharmaceutical Industries Limited and Evotec SE's Expenses
Bio-Techne Corporation vs Ligand Pharmaceuticals Incorporated: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: ACADIA Pharmaceuticals Inc. vs Ligand Pharmaceuticals Incorporated
Cost of Revenue Comparison: Ligand Pharmaceuticals Incorporated vs Iovance Biotherapeutics, Inc.
Cost Insights: Breaking Down Ligand Pharmaceuticals Incorporated and Xencor, Inc.'s Expenses